Key Facts

Invested since 2012
Based in North Rhine-Westphalia

About the company

Sample analysis in structural biology often suffers from weak contrast in the transmission electron microscope (TEM). The KonTEM PhazR solves this contrast problem and thus enables scientists to extract more information about structure and function of cells on molecular level.

Exit since May 2014. Purchaser: FEI Company (NASDAQ: FEIC)

Do you want to

know more about this company?

Zum Artikel

Dr. Andreas Olmes Principal

Dr. Andreas OlmesPrincipal

KonTEM in the news

Zum Artikel

Press

22. May 2014

Profitable exit: KonTEM trade sale to FEI Company (NASDAQ: FEIC)

Zum Artikel

Press

17. April 2012

High-Tech Gründerfonds invests in KonTEM GmbH

More startups from Industrial Tech